Project Details
Projekt Print View

Inhibition of myelin regeneration by tenascin proteins and the associated matrisom

Subject Area Experimental Models for the Understanding of Nervous System Diseases
Developmental Neurobiology
Molecular Biology and Physiology of Neurons and Glial Cells
Term from 2018 to 2022
Project identifier Deutsche Forschungsgemeinschaft (DFG) - Project number 407698736
 
Final Report Year 2023

Final Report Abstract

Myelin sheaths are of fundamental importance for the rapid transmission of action potentials in mammalian nervous systems. Numerous disease processes affect the myelin sheath and myelin deficits result in severe nervous system dysfunction. The repair of myelin lesions is therefore of prime importance for CNS function and homeostasis. Mature oligodendrocytes cannot repair deficient myelin, but oligodendrocyte precursor cells (OPCs) can respond to lesion, proliferate and contribute to the regeneration of myelin. The past years have shown that myelin repair is inhibited by a variety of gene products, including components of the extracellular matrix (ECM), collectively designated as matrisome. In the present project, we have considered two major glycoproteins of the matrisome of the CNS, namely tenascin-C (Tnc) and tenascin-R (Tnr), with reference to myelin regeneration. Using in vitro and in vivo assays and genetically modified mouse lines, we show here that both Tnc and Tnr regulate the development of myelin sheaths in an artificial fiber myelination assay in vitro and inhibit remyelination in ex vivo explants and in a myelin lesion model in vivo. We also demonstrate that tenascin proteins affect the migration of OPCs in vitro and provide evidence that the guanine exchange factor (GEF) Vav3 is part of the signaling pathway that mediates Tncdependent effects. Thereby, we establish the tenascin proteins as important inhibitors of myelin regeneration.

Publications

 
 

Additional Information

Textvergrößerung und Kontrastanpassung